Catherine Alix-Panabières, Director of the Laboratory of Rare Human Circulating Cells and Professor of Universities – Hospital Practitioner at Montpellier University Hospital, shared a post on LinkedIn:
“Honored and grateful for the invitation by Prof. Dr. Dominik Wolf, Director of the Hematology and Oncology Institute, Medizinische Universität Innsbruck (Austria), to deliver this week a lecture in front of the scientific and clinical committee.
“Liquid Biopsy: the rise of a medical revolution – from discovery to clinical application”
An inspiring audience, sharp clinical insights, and truly fruitful discussions bridging fundamental biology and real-world patient care. Exactly the kind of exchange that drives meaningful innovation in Oncology.
Beyond science, Innsbruck is a remarkable place – where snow-covered landscapes help clear the mind, spark imagination, and open space for new ideas in Liquid Biopsy and Precision Medicine.
I was also very happy to learn that the Medizinische Universität Innsbruck will soon join European Liquid Biopsy Society (ELBS) – an exciting step forward.
New collaborations are on the horizon, and I am confident this synergy will translate into impactful advances for patients. A stay perfectly balanced between intense scientific work and restorative moments, in the right place, at the right time.
Looking forward to what comes next.”
More posts featuring Catherine Alix-Panabières on OncoDaily.
